Calendar

Apr 29, 2026phase 1 initiation104d agoOcugen Inc — adenovirus vector (spike protein) vaccine (Phase I Trial Initiation)adenovirus vector (spike protein) vaccine

Therapy area: Infectious Disease. Indication: Coronavirus Disease 2019 (COVID-19)

full page →adenovirus vector (spike protein) vaccine →source: globaldata

Apr 29, 2026phase 2 completion104d agoSaraswati Dhanwantari Dental College and Hospital Parbhani — (amoxicillin + clavulanic acid) (Phase II Trial Completion)(amoxicillin + clavulanic acid)

Therapy area: Infectious Disease, Mouth and Dental Disorders. Indication: Periodontitis, Unspecified Infectious Diseases

full page →(amoxicillin + clavulanic acid) →source: globaldata

Apr 29, 2026phase 2 initiation104d agoYunpeng Pharmaceutical Co Ltd — norfloxacin (Phase II Trial Initiation)norfloxacin

Therapy area: Gastrointestinal, Genito Urinary System, Infectious Disease. Indication: Gonorrhea, Intestinal Infection, Salmonella Infections, Typhoid Fever, Urinary Tract Infections

full page →norfloxacin →source: globaldata

Apr 29, 2026phase 2 initiation104d agoHuahui Health Ltd — HH-006 (Phase II Trial Initiation)HH-006

Therapy area: Infectious Disease. Indication: Hepatitis B

full page →HH-006 →source: globaldata

Week of Apr 27, 2026